Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Ther ; 21(4): e97-9, 2014.
Article in English | MEDLINE | ID: mdl-24158007

ABSTRACT

Serotonin syndrome (SS) is a life-threatening adverse reaction that can result from the therapeutic use of serotonergic drugs or accidental drug interactions. Tramadol is a drug that is widely prescribed because of its low abuse potential, but physicians need to be aware of its significant potential to cause SS because it inhibits serotonin reuptake. Ziprasidone is an atypical antipsychotic that can also cause dangerous interactions to cause SS because it is not only a potent 5-HT1A agonist but also has been reported to inhibit serotonin reuptake with an affinity similar to tricyclic antidepressants, in addition to inhibiting reuptake of norepinephrine. We are describing the clinical characteristics of a gentleman with bipolar disorder and Parkinson disease who presented with SS, despite having a deep brain stimulator in the subthalamic nucleus, which decreases central serotonin levels, and a discussion of the factors that contributed to his presentation.


Subject(s)
Piperazines/adverse effects , Serotonin Syndrome/chemically induced , Serotonin/metabolism , Thiazoles/adverse effects , Tramadol/adverse effects , Aged , Analgesics, Opioid/adverse effects , Analgesics, Opioid/therapeutic use , Antipsychotic Agents/adverse effects , Antipsychotic Agents/pharmacology , Antipsychotic Agents/therapeutic use , Bipolar Disorder/drug therapy , Deep Brain Stimulation/methods , Drug Interactions , Humans , Male , Parkinson Disease/therapy , Piperazines/pharmacology , Piperazines/therapeutic use , Thiazoles/pharmacology , Thiazoles/therapeutic use , Tramadol/pharmacology , Tramadol/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...